Jointown Pharmaceutical Group Co., Ltd (SHA:600998)

Market Cap	24.33B
Revenue (ttm)	155.75B
Net Income (ttm)	2.75B
Shares Out	4.99B
EPS (ttm)	0.54
PE Ratio	9.05
Forward PE	11.70
Dividend	0.20 (4.10%)
Ex-Dividend Date	Jun 17, 2025

Volume	30,875,044
Average Volume	33,567,535
Open	4.930
Previous Close	4.930
Day's Range	4.870 - 4.950
52-Week Range	4.570 - 6.000
Beta	0.27
RSI	36.36
Earnings Date	Oct 28, 2025

About SHA:600998

Jointown Pharmaceutical Group Co., Ltd provides pharmaceutical supply chain services in China. It is also involved in general agency brand promotion; digital retail; intelligent logistics and supply chain solutions; and medical health and technology value-added service businesses. In addition, the company manufactures western medicines, such as antibiotics, anti-diabetic drugs, and cardiovascular drugs; and other OEM medicines. The company was founded in 1999 and is based in Wuhan, China.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 30,169
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600998

Financial Performance

In 2024, SHA:600998's revenue was 151.81 billion, an increase of 1.11% compared to the previous year's 150.14 billion. Earnings were 2.51 billion, an increase of 15.33%.